elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q27693313-6CA1DF80-6786-41F7-841C-FDDB52940BCE
Q27693313-6CA1DF80-6786-41F7-841C-FDDB52940BCE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27693313-6CA1DF80-6786-41F7-841C-FDDB52940BCE
Bispecific T-cell engagers for cancer immunotherapy.
P2860
Q27693313-6CA1DF80-6786-41F7-841C-FDDB52940BCE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27693313-6CA1DF80-6786-41F7-841C-FDDB52940BCE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
159ebaf6cb20f1de31b758903c8b16ff469ab9cd
P2860
Hybrid antibodies can target sites for attack by T cells.